BOSTON, May 3 – Harvard’s Institute of Proteomics will seek to raise $100 million from private and public sources in a bid to develop a repository of full-length cDNA clones that would assist researchers in their efforts to study proteins, Joshua LaBaer, the director of the institute, said Thursday.

“Celera and a number of other companies are planning to do proteomics profiling. We’re looking to be able to produce proteins rather than study them,” said LaBaer following a talk at the Whitehead Institute for Biomedical Research. “We’d like to give everybody access to the clones.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.